In Reply
- PMID: 31288913
- PMCID: PMC6630166
- DOI: 10.3238/arztebl.2019.0345
In Reply
Comment on
-
Critical Comments.Dtsch Arztebl Int. 2019 May 10;116(19):344. doi: 10.3238/arztebl.2019.0344a. Dtsch Arztebl Int. 2019. PMID: 31288911 Free PMC article. No abstract available.
-
Additions.Dtsch Arztebl Int. 2019 May 10;116(19):344-345. doi: 10.3238/arztebl.2019.0344b. Dtsch Arztebl Int. 2019. PMID: 31288912 Free PMC article. No abstract available.
References
-
- Fingerle V, Eiffert H, Gessner A, et al. Lyme Borreliose MiQ - Qualitätsstandards in der mikrobiologisch - infektiologischen Untersuchung. In: Podbielski A, Abele-Horn M, Hermann M, Kniehl E, Mauch H, Rüssmann H, editors. Jena: Elsevier Urban & Fischer. 2. München: 2017.
-
- Klempner MS, Hu LT, Evans J, et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med. 2001;345:85–92. - PubMed
-
- Fallon BA, Keilp JG, Corbera KM, et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology. 2008;70:992–1003. - PubMed
-
- Krupp LB, Hyman LG, Grimson R, et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology. 2003;60:1923–1930. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
